Surgical treatment of intermediate uveitis.
Surgical treatment of intermediate uveitis.
复制标题
中间葡萄膜炎的手术治疗。
DOI：
10.1159/000429650
复制
发表时间：
1992
期刊：
影响因子：
--
通讯作者：
Kaplan,HJ
中科院分区：
文献类型：
--
作者：
Kaplan,HJ
对中间葡萄膜炎的手术干预是一种相对较新的治疗方式，其作用只有在我们对这种疾病可用的整体治疗手段的背景下才能被理解。因此，我的报告将以对中间葡萄膜炎的四步治疗方法的简要概述开始。接下来将讨论玻璃体切割术的治疗效果。最后，将介绍可见光这一新的令人兴奋的观察结果的潜在治疗效果。由于中间葡萄膜炎的持续时间通常有限，因此必须主要注意预防视觉障碍并发症，直到遇到自然静止。我们之前提出了一个治疗中间葡萄膜炎患者的四步方案。第一步是使用全身或眼周皮质类固醇进行免疫抑制。虽然可能存在这种疾病，但除非视力降至或低于20/30，或出现继发性白内障，否则不会进行轻微的对症治疗。皮质激素治疗的细节以前已经讨论过了，不会详细说明。如果遇到对皮质类固醇治疗不耐受或无反应的情况，则达到治疗方案的第二步，即冷冻消融。Aaberg等人[1]报道了冷冻消融对涉及部分性扁平炎的区域的良好反应。他们最近的经验将由Mieler和Aaberg在下一篇论文中介绍。我们使用单一的冻融技术-
Surgical intervention in intermediate uveitis is a relatively new therapeutic modality whose role can only be appreciated in the context of the overall therapeutic armamentarium available to us in this disease. Therefore, my presentation will begin with a brief overview of the four-step treat-ment approach to intermediate uveitis. It will be followed by a discussion of the therapeutic effect of vitrectomy. Finally, the potential therapeutic effect of visible light, a new and exciting observation, will be presented. Since intermediate uveitis is frequently limited in duration, primary attention must be given to prevention of visually disabling complications until a natural quiescence is encountered. We previously proposed a four-step scheme for the treatment of patients with intermediate uveitis. The first step involves the use of systemic or periocular corticosteroids for immunosuppression. Although the disease may be present and mildly symptomatic treatment is not instituted unless visual acuity is reduced to or less than 20/30, or a secondary cataract is noted. The details of corticoster-oid treatment were previously discussed and will not be elaborated upon. If intolerance or unresponsiveness to corticosteroid therapy is encountered, the second step of the therapeutic scheme is reached, namely, cryoablation. Aaberg et al.[1] reported a favorable response to cryoablation in the area of involvement in pars planitis. Their recent experience will be presented by Mieler and Aaberg in the next paper. We use a single freeze-thaw tech-